Our results confirmed that GRN A enhances the inhibitory effect of cisplatin significantly; treatment of the hepatocellular carcinoma with the combination of GRN A and cisplatin leads to more potent inhibitory effect on cancer cells growth, as analyzed by apoptosis and colony formation assay. This evidence concerns the gene GRN and hepatocellular carcinoma.